The Usefulness of Spectral Mammography in Surgical Planning of Breast Cancer Treatment-Analysis of 999 Patients with Primary Operable Breast Cancer

被引:6
|
作者
Lorek, Andrzej [1 ]
Steinhof-Radwanska, Katarzyna [2 ]
Barczyk-Gutkowska, Anna [2 ]
Zarebski, Wojciech [1 ]
Palen, Piotr [3 ]
Szyluk, Karol [4 ]
Lorek, Joanna [5 ]
Grazynska, Anna [6 ]
Niemiec, Pawel [7 ]
Gisterek, Iwona [8 ]
机构
[1] Med Univ Silesia, Prof Kornel Gibinski Independent Publ Cent Clin H, Dept Oncol Surg, PL-40514 Katowice, Poland
[2] Med Univ Silesia, Prof Kornel Gibinski Independent Publ Cent Clin H, Dept Radiol & Nucl Med, PL-40514 Katowice, Poland
[3] Med Univ Silesia, Prof Kornel Gibinski Independent Publ Cent Clin H, Dept Pathomorphol & Mol Diagnost, PL-40752 Katowice, Poland
[4] Dist Hosp Orthopaed & Trauma Surg, Dept Orthopaed & Trauma Surg, PL-41940 Piekary Slaskie, Poland
[5] Ludwig Rydygier Hosp Sp Zoo, Dept Surg, PL-31826 Krakow, Poland
[6] Med Univ Silesia, Dept Radiol & Nucl Med, Students Sci Soc, PL-40514 Katowice, Poland
[7] Med Univ Silesia, Sch Hlth Sci, Dept Biochem & Med Genet, PL-40752 Katowice, Poland
[8] Med Univ Silesia, Prof Kornel Gibinski Independent Publ Cent Clin H, Dept Oncol & Radiotherapy, PL-40514 Katowice, Poland
关键词
breast cancer; contrast-enhanced spectral mammography; mammography; comparative studies; pathology; surgery; DIAGNOSTIC-ACCURACY; DIGITAL MAMMOGRAPHY; PRIMARY THERAPY; WOMEN; MANAGEMENT; TUMOR; MRI; PERFORMANCE; CARCINOMA; CONSENSUS;
D O I
10.3390/curroncol28040232
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Contrast-enhanced spectral mammography (CESM) is a promising, digital breast imaging method for planning surgeries. The study aimed at comparing digital mammography (MG) with CESM as predictive factors in visualizing multifocal-multicentric cancers (MFMCC) before determining the surgery extent. We analyzed 999 patients after breast cancer surgery to compare MG and CESM in terms of detecting MFMCC. Moreover, these procedures were assessed for their conformity with postoperative histopathology (HP), calculating their sensitivity and specificity. The question was which histopathological types of breast cancer were more frequently characterized by multifocality-multicentrality in comparable techniques as regards the general number of HP-identified cancers. The analysis involved the frequency of post-CESM changes in the extent of planned surgeries. In the present study, MG revealed 48 (4.80%) while CESM 170 (17.02%) MFMCC lesions, subsequently confirmed in HP. MG had MFMCC detecting sensitivity of 38.51%, specificity 99.01%, PPV (positive predictive value) 85.71%, and NPV (negative predictive value) 84.52%. The respective values for CESM were 87.63%, 94.90%, 80.57% and 96.95%. Moreover, no statistically significant differences were found between lobular and NST cancers (27.78% vs. 21.24%) regarding MFMCC. A treatment change was required by 20.00% of the patients from breast-conserving to mastectomy, upon visualizing MFMCC in CESM. In conclusion, mammography offers insufficient diagnostic sensitivity for detecting additional cancer foci. The high diagnostic sensitivity of CESM effectively assesses breast cancer multifocality/multicentrality and significantly changes the extent of planned surgeries. The multifocality/multicentrality concerned carcinoma, lobular and invasive carcinoma of no special type (NST) cancers with similar incidence rates, which requires further confirmation.
引用
收藏
页码:2548 / 2559
页数:12
相关论文
共 50 条
  • [41] Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI?
    Heil, J.
    Buehler, A.
    Golatta, M.
    Rom, J.
    Schipp, A.
    Harcos, A.
    Schneeweiss, A.
    Rauch, G.
    Sohn, C.
    Junkermann, H.
    ANNALS OF ONCOLOGY, 2012, 23 (01) : 98 - U200
  • [42] Contrast-Enhanced Mammography and Radiomics Analysis for Noninvasive Breast Cancer Characterization: Initial Results
    Marino, Maria Adele
    Pinker, Katja
    Leithner, Doris
    Sung, Janice
    Avendano, Daly
    Morris, Elizabeth A.
    Jochelson, Maxine
    MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (03) : 780 - 787
  • [43] Risk-benefit analysis of preoperative breast MRI in patients with primary breast cancer
    Siegmann, K. C.
    Baur, A.
    Vogel, U.
    Kraemer, B.
    Hahn, M.
    Claussen, C. D.
    CLINICAL RADIOLOGY, 2009, 64 (04) : 403 - 413
  • [44] Evaluation of waiting times for breast cancer diagnosis and surgical treatment
    Baena-Canada, J. M.
    Rodriguez-Perez, L.
    Gamez-Casado, S.
    Quilez-Cutillas, A.
    Cortes-Carmona, C.
    Rosado-Varela, P.
    Estalella-Mendoza, S.
    Ramirez-Daffos, P.
    Jaen-Olasolo, J.
    Benitez-Rodriguez, E.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (10) : 1345 - 1352
  • [45] A PRELIMINARY STUDY OF RISK FACTORS OF BREAST CANCER AND THE USEFULNESS OF BREAST MRI AS AN ADDITION TO MAMMOGRAPHY IN DETECTING BREAST CANCER IN HIGH RISK WOMEN
    Karim, Noor Khairiah A.
    Hami, Rohayu
    Hashim, Nur Hashamimi
    Azman, Nizuwan
    Shuaib, Ibrahim Lutfi
    JURNAL TEKNOLOGI, 2016, 78 (11-3): : 27 - 34
  • [46] Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer
    Willsher, PC
    Robertson, JFR
    Jackson, L
    AlHilaly, M
    Blamey, RW
    BREAST, 1997, 6 (03) : 150 - 154
  • [47] Dual-energy contrast-enhanced spectral mammography (CESM) for breast cancer screening
    Sorin, Vera
    Sklair-Levy, Miri
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2019, 9 (11) : 1914 - 1917
  • [48] Accuracy of Tumor Size Measurements During Mammography and Breast Ultrasonography in Breast Cancer Patients
    Oprea, Adela-Luciana
    Georgescu, Rares
    Ionescu, Paul
    Marginean, Claudiu
    PROCEEDINGS OF THE 6TH CONGRESS OF THE ULTRASOUND SOCIETY IN OBSTETRICS AND GYNECOLOGY / 34TH FETUS AS A PATIENT INTERNATIONAL CONGRESS, 2018, : 409 - 416
  • [49] Diagnostic Value of Contrast-Enhanced Spectral Mammography for Screening Breast Cancer: Systematic Review and Meta-analysis
    Zhu, Xiao
    Huang, Jun-ming
    Zhang, Kun
    Xia, Long-jie
    Feng, Lan
    Yang, Ping
    Zhang, Meng-ya
    Xiao, Wei
    Lin, Hui-xia
    Yu, Ying-hua
    CLINICAL BREAST CANCER, 2018, 18 (05) : E985 - E995
  • [50] Risk of second primary cancer after breast cancer treatment
    Marcu, L. G.
    Santos, A.
    Bezak, E.
    EUROPEAN JOURNAL OF CANCER CARE, 2014, 23 (01) : 51 - 64